O	0	6	Effect
O	7	9	of
B-condition	10	16	weight
I-condition	17	21	loss
O	21	22	,
O	23	27	with
O	28	30	or
O	31	38	without
B-intervention	39	47	exercise
O	47	48	,
O	49	51	on
O	52	56	body
O	57	68	composition
O	69	72	and
O	73	76	sex
O	77	85	hormones
O	86	88	in
O	89	103	postmenopausal
O	104	109	women
O	109	110	:
O	111	114	the
O	115	120	SHAPE
O	120	121	-
O	121	122	2
O	123	128	trial
O	128	129	.

O	130	138	Physical
O	139	149	inactivity
O	150	153	and
O	154	164	overweight
O	165	168	are
O	169	173	risk
O	174	181	factors
O	182	185	for
O	186	200	postmenopausal
O	201	207	breast
O	208	214	cancer
O	214	215	.

O	216	219	The
O	220	226	effect
O	227	229	of
O	230	238	physical
O	239	247	activity
O	248	251	may
O	252	254	be
O	255	264	partially
O	265	273	mediated
O	274	276	by
O	277	287	concordant
O	288	294	weight
O	295	299	loss
O	299	300	.

O	301	303	We
O	304	311	studied
O	312	315	the
O	316	322	effect
O	323	325	on
O	326	331	serum
O	332	335	sex
O	336	344	hormones
O	344	345	,
O	346	351	which
O	352	355	are
O	356	361	known
O	362	364	to
O	365	367	be
O	368	378	associated
O	379	383	with
O	384	398	postmenopausal
O	399	405	breast
O	406	412	cancer
O	413	417	risk
O	417	418	,
O	419	423	that
O	424	426	is
O	427	439	attributable
O	440	442	to
O	443	451	exercise
O	452	454	by
O	455	464	comparing
O	465	473	randomly
O	474	482	obtained
O	483	493	equivalent
O	494	500	weight
O	501	505	loss
O	506	508	by
O	509	518	following
O	519	520	a
O	521	532	hypocaloric
O	533	537	diet
O	538	542	only
O	543	545	or
O	546	552	mainly
O	553	555	by
O	556	564	exercise
O	564	565	.

B-eligibility	566	576	Overweight
I-eligibility	576	577	,
I-eligibility	578	592	insufficiently
I-eligibility	593	599	active
I-eligibility	600	605	women
O	606	610	were
O	611	621	randomised
O	622	624	to
O	625	626	a
O	627	631	diet
O	632	633	(
O	633	634	N
O	635	636	=
B-intervention-participants	637	639	97
O	639	640	)
O	640	641	,
O	642	648	mainly
O	649	657	exercise
O	658	659	(
O	659	660	N
O	661	662	=
B-intervention-participants	663	665	98
O	665	666	)
O	667	669	or
B-control	670	677	control
I-control	678	683	group
O	684	685	(
O	685	686	N
O	687	688	=
B-control-participants	689	691	48
O	691	692	)
O	692	693	.

O	694	697	The
O	698	702	goal
O	703	705	of
O	706	710	both
O	711	724	interventions
O	725	728	was
O	729	731	to
O	732	739	achieve
O	740	741	5
O	741	742	-
O	742	743	6
O	744	746	kg
O	747	749	of
O	750	756	weight
O	757	761	loss
O	762	764	by
O	765	774	following
O	775	776	a
O	777	784	calorie
O	784	785	-
O	785	795	restricted
O	796	800	diet
O	801	803	or
O	804	806	an
O	807	816	intensive
O	817	825	exercise
O	826	835	programme
O	836	844	combined
O	845	849	with
O	850	854	only
O	855	856	a
O	857	862	small
O	863	870	caloric
O	871	882	restriction
O	882	883	.

O	884	891	Primary
O	892	900	outcomes
O	901	906	after
O	907	909	16
O	910	915	weeks
O	916	920	were
B-outcome-Measure	921	926	serum
I-outcome-Measure	927	930	sex
I-outcome-Measure	931	939	hormones
O	940	943	and
B-outcome-Measure	944	947	sex
I-outcome-Measure	948	955	hormone
I-outcome-Measure	955	956	-
I-outcome-Measure	956	963	binding
I-outcome-Measure	964	972	globulin
I-outcome-Measure	973	974	(
I-outcome-Measure	974	978	SHBG
I-outcome-Measure	978	979	)
O	979	980	.

B-outcome-Measure	981	985	Body
I-outcome-Measure	986	989	fat
I-outcome-Measure	990	993	and
I-outcome-Measure	994	998	lean
I-outcome-Measure	999	1003	mass
O	1004	1008	were
O	1009	1017	measured
O	1018	1020	by
O	1021	1025	dual
O	1025	1026	-
O	1026	1032	energy
O	1033	1034	X
O	1034	1035	-
O	1035	1038	ray
O	1039	1053	absorptiometry
O	1053	1054	.

O	1055	1059	Both
O	1060	1063	the
O	1064	1068	diet
O	1069	1070	(
O	1070	1071	-
O	1071	1072	4
O	1072	1073	.
O	1073	1074	9
O	1075	1077	kg
O	1077	1078	)
O	1079	1082	and
O	1083	1089	mainly
O	1090	1098	exercise
O	1099	1100	(
O	1100	1101	-
O	1101	1102	5
O	1102	1103	.
O	1103	1104	5
O	1105	1107	kg
O	1107	1108	)
O	1109	1115	groups
O	1116	1124	achieved
O	1125	1128	the
B-outcome	1129	1135	target
I-outcome	1136	1142	weight
I-outcome	1143	1147	loss
O	1147	1148	.

B-outcome	1149	1153	Loss
I-outcome	1154	1156	of
I-outcome	1157	1161	body
I-outcome	1162	1165	fat
O	1166	1169	was
O	1170	1183	significantly
O	1184	1191	greater
O	1192	1196	with
O	1197	1205	exercise
O	1206	1212	versus
O	1213	1217	diet
O	1218	1219	(
O	1219	1229	difference
O	1230	1231	-
O	1231	1232	1
O	1232	1233	.
O	1233	1234	4
O	1235	1237	kg
O	1237	1238	,
O	1239	1240	P
O	1241	1242	<
O	1243	1244	0
O	1244	1245	.
O	1245	1248	001
O	1248	1249	)
O	1249	1250	.

O	1251	1253	In
O	1254	1257	the
O	1258	1264	mainly
O	1265	1273	exercise
O	1274	1277	arm
O	1277	1278	,
O	1279	1282	the
O	1283	1292	reduction
O	1293	1295	in
O	1296	1300	free
B-outcome	1301	1313	testosterone
O	1314	1317	was
O	1318	1331	statistically
O	1332	1345	significantly
O	1346	1353	greater
O	1354	1358	than
O	1359	1363	that
O	1364	1366	of
O	1367	1370	the
O	1371	1375	diet
O	1376	1379	arm
O	1380	1381	(
O	1381	1390	treatment
O	1391	1397	effect
O	1398	1403	ratio
O	1404	1405	[
O	1405	1408	TER
O	1408	1409	]
O	1410	1411	0
O	1411	1412	.
O	1412	1414	92
O	1414	1415	,
O	1416	1417	P
O	1418	1419	=
O	1420	1421	0
O	1421	1422	.
O	1422	1425	043
O	1425	1426	)
O	1426	1427	,
O	1428	1431	and
O	1432	1435	the
O	1436	1443	results
O	1444	1448	were
O	1449	1459	suggestive
O	1460	1462	of
O	1463	1464	a
O	1465	1475	difference
O	1476	1479	for
B-outcome	1480	1495	androstenedione
O	1496	1497	(
O	1497	1500	TER
O	1501	1502	0
O	1502	1503	.
O	1503	1505	90
O	1505	1506	,
O	1507	1508	P
O	1509	1510	=
O	1511	1512	0
O	1512	1513	.
O	1513	1516	064
O	1516	1517	)
O	1518	1521	and
B-outcome	1522	1526	SHBG
O	1527	1528	(
O	1528	1531	TER
O	1532	1533	1
O	1533	1534	.
O	1534	1536	05
O	1536	1537	,
O	1538	1539	P
O	1540	1541	=
O	1542	1543	0
O	1543	1544	.
O	1544	1547	070
O	1547	1548	)
O	1548	1549	.

O	1550	1558	Compared
O	1559	1563	with
O	1564	1567	the
O	1568	1575	control
O	1576	1579	arm
O	1579	1580	,
B-outcome	1581	1591	beneficial
I-outcome	1592	1599	effects
O	1600	1604	were
O	1605	1609	seen
O	1610	1614	with
O	1615	1619	both
O	1620	1633	interventions
O	1633	1634	,
O	1635	1639	diet
O	1640	1643	and
O	1644	1650	mainly
O	1651	1659	exercise
O	1659	1660	,
O	1661	1673	respectively
O	1673	1674	,
O	1675	1677	on
B-outcome	1678	1688	oestradiol
O	1689	1690	(
O	1690	1693	TER
O	1694	1695	0
O	1695	1696	.
O	1696	1698	86
O	1698	1699	,
O	1700	1701	P
O	1702	1703	=
O	1704	1705	0
O	1705	1706	.
O	1706	1709	025
O	1709	1710	;
O	1711	1714	TER
O	1715	1716	0
O	1716	1717	.
O	1717	1719	83
O	1719	1720	,
O	1721	1722	P
O	1723	1724	=
O	1725	1726	0
O	1726	1727	.
O	1727	1730	007
O	1730	1731	)
O	1731	1732	,
B-outcome	1733	1737	free
I-outcome	1738	1748	oestradiol
O	1749	1750	(
O	1750	1753	TER
O	1754	1755	0
O	1755	1756	.
O	1756	1758	80
O	1758	1759	,
O	1760	1761	P
O	1762	1763	=
O	1764	1765	0
O	1765	1766	.
O	1766	1769	002
O	1769	1770	;
O	1771	1774	TER
O	1775	1776	0
O	1776	1777	.
O	1777	1779	77
O	1779	1780	,
O	1781	1782	P
O	1783	1784	<
O	1785	1786	0
O	1786	1787	.
O	1787	1790	001
O	1790	1791	)
O	1791	1792	,
B-outcome	1793	1797	SHBG
O	1798	1799	(
O	1799	1802	TER
O	1803	1804	1
O	1804	1805	.
O	1805	1807	14
O	1807	1808	;
O	1809	1812	TER
O	1813	1814	1
O	1814	1815	.
O	1815	1817	21
O	1817	1818	,
O	1819	1823	both
O	1824	1825	P
O	1826	1827	<
O	1828	1829	0
O	1829	1830	.
O	1830	1833	001
O	1833	1834	)
O	1835	1838	and
B-outcome	1839	1843	free
I-outcome	1844	1856	testosterone
O	1857	1858	(
O	1858	1861	TER
O	1862	1863	0
O	1863	1864	.
O	1864	1866	91
O	1866	1867	,
O	1868	1869	P
O	1870	1871	=
O	1872	1873	0
O	1873	1874	.
O	1874	1877	069
O	1877	1878	;
O	1879	1882	TER
O	1883	1884	=
O	1885	1886	0
O	1886	1887	.
O	1887	1889	84
O	1889	1890	,
O	1891	1892	P
O	1893	1894	=
O	1895	1896	0
O	1896	1897	.
O	1897	1900	001
O	1900	1901	)
O	1901	1902	.

O	1903	1908	After
O	1909	1919	adjustment
O	1920	1923	for
O	1924	1931	changes
O	1932	1934	in
O	1935	1939	body
O	1940	1943	fat
O	1943	1944	,
O	1945	1957	intervention
O	1958	1965	effects
O	1966	1976	attenuated
O	1977	1979	or
O	1980	1991	disappeared
O	1991	1992	.

O	1993	1999	Weight
O	2000	2004	loss
O	2005	2009	with
O	2010	2014	both
O	2015	2028	interventions
O	2029	2037	resulted
O	2038	2040	in
O	2041	2051	favourable
O	2052	2059	effects
O	2060	2062	on
O	2063	2068	serum
O	2069	2072	sex
O	2073	2081	hormones
O	2081	2082	,
O	2083	2088	which
O	2089	2093	have
O	2094	2098	been
O	2099	2104	shown
O	2105	2107	to
O	2108	2110	be
O	2111	2121	associated
O	2122	2126	with
O	2127	2128	a
O	2129	2137	decrease
O	2138	2140	in
O	2141	2155	postmenopausal
O	2156	2162	breast
O	2163	2169	cancer
O	2170	2174	risk
O	2174	2175	.

O	2176	2182	Weight
O	2183	2187	loss
O	2188	2195	induced
O	2196	2202	mainly
O	2203	2205	by
O	2206	2214	exercise
O	2215	2227	additionally
O	2228	2236	resulted
O	2237	2239	in
O	2240	2251	maintenance
O	2252	2254	of
O	2255	2259	lean
O	2260	2264	mass
O	2264	2265	,
O	2266	2273	greater
O	2274	2281	fitness
O	2281	2282	,
O	2283	2290	greater
O	2291	2294	fat
O	2295	2299	loss
O	2300	2303	and
O	2304	2305	a
O	2306	2312	larger
O	2313	2319	effect
O	2320	2322	on
O	2323	2324	(
O	2324	2328	some
O	2328	2329	)
O	2330	2333	sex
O	2334	2342	hormones
O	2342	2343	.

O	2344	2347	The
O	2348	2355	greater
O	2356	2359	fat
O	2360	2364	loss
O	2365	2371	likely
O	2372	2380	explains
O	2381	2384	the
O	2385	2393	observed
O	2394	2400	larger
O	2401	2408	effects
O	2409	2411	on
O	2412	2415	sex
O	2416	2424	hormones
O	2424	2425	.

O	2426	2440	ClinicalTrials
O	2440	2441	.
O	2441	2444	gov
O	2445	2455	identifier
O	2455	2456	:
O	2457	2468	NCT01511276
O	2469	2470	.

O	2471	2481	Registered
O	2482	2484	on
O	2485	2487	12
O	2488	2495	January
O	2496	2500	2012
O	2500	2501	.
